NCT00786188 · Interventional trial
Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause
Overall registry status Completed
Phase 2
Conditions Hot Flashes
Delaware Valley sites
- Philadelphia Clinical Research · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory